Janssen Expands its Collaboration with BARDA to Expedite the Discovery of COVID-19 Therapies

 Janssen Expands its Collaboration with BARDA to Expedite the Discovery of COVID-19 Therapies

Janssen Expands its Collaboration with BARDA to Expedite the Discovery of COVID-19 Therapies

Shots:

  • The public-private collaboration will expand Janssen’s ongoing work with global partners to screen a library of existing antiviral molecules, with the goal to identify compounds with antiviral activity against SARS-CoV-2
  • As per the collaboration, partners will share the research and development costs and mobilize resources to screen a library of antiviral molecules for activity against SARS-CoV-2
  • Janssen will utilize its antiviral expertise with Rega Institute for Medical Research’s high throughput screening experience & capabilities for the screening of compounds in Belgium

Click here ­to­ read full press release/ article | Ref: JNJ | Image: Pharmafile

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post